tegafur has been researched along with Digestive System Neoplasms in 8 studies
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For 27 outpatients with advanced cancer of the digestive system including 15 cases of esophageal cancer, 4 cases of gastric cancer, 3 cases of colon cancer, 4 cases of pancreatic cancer and 1 case of gall bladder cancer, 4 to 6 week home adjuvant chemotherapy was performed." | 2.68 | [Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy]. ( Araki, H; Hiramatsu, Y; Kamiyama, Y; Kojima, Y; Nakagawa, A; Nakagawa, M; Ogura, T; Shirasaka, T, 1995) |
| " Thus, the reduced efficacy of standard chemotherapy dosage in Chinese cancer patients may be explained by the lack of CYP2A6-mediated S-1 bioconversion to 5-FU." | 1.38 | Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy. ( Fang, WJ; Huang, MZ; Jin, DZ; Mao, CY; Mou, HB; Peng, L; Xu, N; Zhao, P; Zheng, YL, 2012) |
| " However, many patients are often forced to give up long-term S-1 treatment owing to high incidence rates of adverse effects." | 1.36 | [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan]. ( Hazama, S; Nakazawa, S; Suga, T; Watanabe, S; Yagi, M; Yoshino, S, 2010) |
| "Improvement of oral mucositis was associated with a significant decrease of intestinal permeability to lactulose." | 1.31 | Intestinal permeability in patients with chemotherapy-induced stomatitis. ( Brátová, M; Kohout, P; Králícková, P; Melichar, B; Solichová, D; Zadák, Z, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yagi, M | 1 |
| Watanabe, S | 1 |
| Yoshino, S | 1 |
| Hazama, S | 1 |
| Suga, T | 1 |
| Nakazawa, S | 1 |
| Fang, WJ | 1 |
| Mou, HB | 1 |
| Jin, DZ | 1 |
| Zheng, YL | 1 |
| Zhao, P | 1 |
| Mao, CY | 1 |
| Peng, L | 1 |
| Huang, MZ | 1 |
| Xu, N | 1 |
| Ibayashi, J | 1 |
| Ogura, T | 1 |
| Hiramatsu, Y | 1 |
| Araki, H | 1 |
| Kojima, Y | 1 |
| Nakagawa, A | 1 |
| Nakagawa, M | 1 |
| Kamiyama, Y | 1 |
| Shirasaka, T | 1 |
| Melichar, B | 1 |
| Kohout, P | 1 |
| Brátová, M | 1 |
| Solichová, D | 1 |
| Králícková, P | 1 |
| Zadák, Z | 1 |
| Shparyk, IaV | 1 |
| Aoki, Y | 1 |
| Tabuse, Y | 1 |
| Tanimura, H | 1 |
| Katsumi, M | 1 |
| Asae, M | 1 |
| Ichimiya, G | 1 |
| Imai, T | 1 |
| Ooshima, K | 1 |
| Kakihara, M | 1 |
| Kashitani, M | 1 |
| Borisov, VI | 1 |
| Mamontov, AS | 1 |
| Ass, NIa | 1 |
1 review available for tegafur and Digestive System Neoplasms
| Article | Year |
|---|---|
[Chemotherapy of tumors of the gastrointestinal tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Digestive System Neoplasms | 1985 |
3 trials available for tegafur and Digestive System Neoplasms
| Article | Year |
|---|---|
[Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
Topics: Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 1995 |
[Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neo | 1989 |
[Chemotherapy of tumors of the gastrointestinal tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Digestive System Neoplasms | 1985 |
5 other studies available for tegafur and Digestive System Neoplasms
| Article | Year |
|---|---|
[Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Digestive System Neoplas | 2010 |
Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Base Sequen | 2012 |
[Cooperative phase II study of releasing tegafur (SF-SP) against advanced digestive cancers].
Topics: Administration, Oral; Adult; Aged; Colonic Neoplasms; Delayed-Action Preparations; Digestive System | 1984 |
Intestinal permeability in patients with chemotherapy-induced stomatitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Digestive System Neoplasms | 2001 |
[The dynamic indices of the natural killer cells in the chemotherapy of patients with digestive organ cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Digestive System Neoplasm | 1990 |